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Background: OA is a complex disease caused by environmental and genetic risk factors. The purpose of this study
is to identify candidate copy number variations (CNVs) associated with OA.
Methods: We performed a genome-wide association study of CNV to identify potential loci that confer susceptibility
to or protection from OA. CNV genotyping was conducted using NimbleGen HD2 3 × 720K comparative hybridization
array and included samples from 371 OA patients and 467 healthy controls. The putative CNV regions identified were
confirmed with a TaqMan assay.
Results: We identified six genomic regions associated with OA encompassing CNV loci. None of six loci had previously
been reported in genome-wide association studies with OA, although a genetic analysis suggested that they have
functional effects. The protein product of a candidate risk gene for obesity, TNKS, targets Wnt inhibition, and this gene
was significantly associated with hand and knee OA. Copy number deletion on TNKS was associated with a 1.37-fold
decreased risk for OA. In addition, CA10, which shows a strong association with osteoporosis, was also significant in our
study. Copy number deletion on this gene was associated with a 1.69-fold decreased risk for OA.
Conclusion: We identified several CNV loci that may contribute to OA susceptibility in Koreans. Further functional
investigations of these genes are warranted to fully characterize their putative association.
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Osteoarthritis (OA), which is also known as degenerative
arthritis, is a disease of mechanical dysfunction involving
degradation of joint components, especially articular car-
tilage and subchondral bone [1]. OA is the most com-
mon form of arthritis that affects elderly people and
often leads to physical disability and reduced quality of
life. OA is a leading cause of impaired mobility in the
elderly [2]. The clinical course of OA varies from min-
imal joint pain, stiffness, and limitations in function to
complete disability.* Correspondence: jylee@cdc.go.kr
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unless otherwise stated.Development of OA is the consequence of interaction
between external stimuli, such as mechanical loading
and the structure and physiology of the joint [3]. Risk
factors of OA include obesity, knee injury, previous knee
surgery, and occupational bending and lifting [4]. Symp-
toms may include joint pain, tenderness, stiffness, lock-
ing, and sometimes an effusion from the affected joint.
Various causes including genetic predisposition, develop-
mental, metabolic, and mechanical deficits can initiate
inflammatory processes that lead to loss of cartilage and
clinically overt OA. Not only mechanical and inflamma-
tory stimuli to joint but also genetic susceptibility to
such stimuli contribute to the pathogenesis of OA.
Recently, a number of genetic association studies for
OA have been performed using candidate gene ap-
proaches or genome-wide association studies (GWASs).This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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OA. GDF5 [5,6], DUS4L [7], 7q22 [8], MCF2L [9] and
GNL3 [10] meet the strict criteria of genome-wide sig-
nificance level with a P-value of < 5 ×10-8. In addition to
these genes, several candidate single-nucleotide polymor-
phisms (SNPs) in FRZB, DIO2, and SMAD2 are regarded
as potentially associated genes [11-13]. However, the con-
siderable number of SNPs in OA most likely reflects the
polygenic nature of the disease with modest effect sizes
for individual genes [14] and may be related to the some-
what inconclusive findings of these studies. Hence, novel
approaches beyond GWASs are warrant.
Copy number variations (CNVs) account for a major
proportion of human genetic polymorphisms and have
been predicted to play an important role in genetic sus-
ceptibility to common diseases [15]. CNVs are one type
of promising structural variation beyond SNPs, which
affect only a single nucleotide. CNVs may range from ~1
kilobase to several megabases in size and can result in
cellular dysfunction. CNVs associated with OA have not
been elucidated.
The purpose of this study is to identify candidate
CNVs associated with OA. To examine the contribution
of a CNV region to OA, we carried out a genome-wide
association analysis between selected CNV regions and
OA. This study revealed potential genetic variants that
had not been previously reported from GWASs.
Methods
Study population
A total of 10038 individuals from the Korean Genome and
Epidemiology Study, which is an ongoing prospective
community-based epidemiology study in the communities
of Ansung (rural) and Ansan (urban) were included. From
that group, 838 individuals (371 OA cases and 467 healthy
controls) who consented to X-ray examination were geno-
typed with NimbleGen HD2 3 × 720K comparative gen-
omic hybridization array (aCGH). All the participants
including controls provided written informed consent.
And the study was approved by the ethics committee of
Korea Centers for Disease Control and Prevention Institu-
tional Review Board. The basic characteristics of the study
participants are summarized in Table 1.
Diagnostic criteria
OA phenotype was diagnosed based on clinical and
radiographic findings without assessment of symptoms.Table 1 Basic characteristics of study subjects
OA phenotype Number Gender (%w
Cases Controls Cases Cont
ROA One definite osteophyte (original K ≥2) 371 467 84% 80%
BMIa: body mass index.Alternative methods of assessment such as self-reported
and symptomatic OA could not be used in this study.
Participants who agreed to undergo X-rays had both
wrists and both knees examined. Radiographic OA was
assessed based on the Kellgren/Lawrence (K/L) grading
system. Patients with K/L grades of 2 or higher in the
wrists or knees were diagnosed as OA [16].
CNV genotyping platform
NimbleGen 3 × 720 aCGH was used for CNV calling.
This platform provides more than 720000 probes. A
total of 360000 probes distributed uniformly across the
entire human genome, whereas another 360000 probes
distributed on targeted location. The median inter-probe
spacing of the backbone is < 5 kb. DNA from the
NA10851 cell line was used as a reference for the aCGH
to extract signal intensity ratio with hg18/NCBI build 36.
To adjust systemic biases that are present in microarray
experiment, all of samples passed experimental control
metrics such as chromosome X shift and mad.1dr with
NimbleScan v.2.5. After quality control, signal intensity ra-
tio of each probe was converted into log2 scale with the
positions of probes.
CNV calling
To conduct reliable CNV association analyses, we di-
vided the CNV calling process into two stages: CNV de-
tection and CNV genotyping (Additional file 1). For
CNV detection, the Genome Alteration Detection Ana-
lysis algorithm (GADA) was used for CNV discovery with
T = 10, alpha = 0.2, and MinSegLen = 10 [17]. An average
log2 ratio of ±0.25 of probes was set as a cut-off value to
define the CNV region. To overcome the limitation of sin-
gle algorithm detection, we tested CNV discovery with
several parameters to find best parameter using known
CNV region. Consequently, we select best parameter with
highly concordant with known CNV region.
Genotype estimation
We used the software package, CNVtools with default
parameters to assign individuals to each CNV genotype
[18]. Particularly, estimated genotype from a linear dis-
crimination function (LDF) of CNVtools was used for
association analysis (Additional file 2). A mixture-based
model used in CNVtools can separate samples into more
exact CNV genotype group. To do this, all individuals of
each CNV regions from the CNV detection with GADAomen) Age (mean) BMIa (mean)
rols P-value Cases Controls P-value Cases Controls P-value
0.1974 62.22 61.23 0.023 25.55 24.28 1.3 × 10-7
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sample and reference sample. Additional file 3 shows
type of CNV class. It is not easy to discriminant exact
CNV genotype in the single-class CNVs, in which all in-
dividuals of the CNV region belonged to one cluster. On
the contrary, multi-class CNVs that consisted of more
than two clusters can assign highly confident CNV geno-
type. Therefore, only well-clustered multi-class CNV re-
gions were included for further study. All CNV regions
were also manually inspected.
Given low frequency or rare CNVs, if the number of
individuals in a cluster was more than three (tripleton),
we regarded this cluster as an independent cluster,
whereas if the number of individuals in a cluster was
two or fewer (doubleton), we did not consider this clus-
ter as a new cluster.
Statistical analysis
Statistical analyses were performed to identify significant
variant associations with hand and/or knee OA using
the R package version 3.0.2. Logistic regression analysis
adjusting for gender, age and BMI as covariates was used
to calculate the statistical significance for cases-control
analysis. Regarding the genotype coding scheme, 0 and 1
were used for two-class CNV regions. Heterozygous de-
letion (one copy) and normal (two copies) were coded as
0 and 1, respectively. For three-class CNV regions,
homozygous deletion (zero copies), heterozygous dele-
tion (one copy) and normal (two copies) were coded as
0, 1, and 2, respectively.Validation of CNVs
To verify estimated CNV regions, we carried out quanti-
tative PCR using the TaqMan Copy Number Assay (Life
Technologies, Foster City, USA) according to the manu-
facturer’s protocols. In total, four pre-designed and two
customized probes were used to validate the existence of
the CNV. Validation samples (cases and controls) were
randomly selected from each estimated genotype cluster.
All validation experiments were replicated 3 times to in-
crease the validation accuracy. The copy number in each
individual was calculated with Copy Caller v2.0 using
the comparative CT method according to the manufac-
turer’s protocols.Results
Study population of each OA type
A total of 371 patients (310 women, 61 men) were thus
diagnosed as having OA (Table 1). The proportion of fe-
male was 84% in cases and 80% in controls, respectively.
Among 371 cases, 204 and 167 were cases of hand and
knee OA, respectively (Table 2).Selection of candidate CNV regions
To estimate the reliable CNV genotype of each individ-
ual, we selected multi-class CNV regions that were well
separated between clusters. Additional file 3 shows an
example of a multi-class cluster that we selected. In
total, 1123 multi-class CNV regions were selected for
the association study. Among these, 463 CNV regions
were two-class regions (one and two copies) and 660
were three-class regions (zero, one and two copies)
(Additional file 3). In addition, we mainly focused on
copy-number deletion rather than copy-number duplica-
tion due to convenience of detection and validation.
Statistical analysis
We conducted logistic regression analyses between iden-
tified CNV regions and OA. Consequently, we selected
six candidate CNV loci that were associated with OA
and that ranged from about ~1 kb to 18.5 kb (Table 3).
Four CNV regions were within genic region (intron),
and the other two regions were in non-genic region (in-
ter-genic). After adjusting for gender, age and BMI, the
P-values of the six CNV regions still satisfied a nominal
P-value threshold of < 0.05 in hand and/or knee OA.
Experimental validation to assess accuracy
To assess the accuracy of CNV estimation, we per-
formed validation experiments with the six significant
CNV regions. Table 4 shows the validation results of
these six regions. The positive predictive value was ap-
plied as a measurement standard of accuracy and indi-
cated the proportions of positive results in the CNV
validations. The average positive predictive value of our
CNV validation results was 0.973, indicating that the CNV
genotype estimation was highly reliable. Additional file 4
shows the TaqMan assay result of the CNV on chromo-
some 8. The estimated CNV genotype (Additional file 4
(A)) was highly concordant with the validated genotype
(Additional file 4 (B)). Except for the CNV region on
chromosome 9, the genotypes of the five regions were
zero, one, and two copies (Table 4).
Discussion
In this study we conducted a genome-wide association
study of CNVs in OA to identify genomic regions that
confer susceptibility and/or protection. The genome-
wide significance level following Bonferroni correction
for the 1123 CNV regions in this study was 4.5 × 10-5.
Because not every variant that has a functional impact al-
ways satisfies a genome-wide significant level and because
relatively small sample size can undermine the reliability
of true variants, some variants with evidence obtained
from genetic study are suggested to have functional ef-
fects, even though none of identified variants meet a
genome-wide significance level. Thus, we investigated





Exact OA definition Knee OA Wrist OA
Cases Controls Cases Controls
KAREa K/L score 2 One definite osteophyte (original K ≥2) 167 467 204 467
aKARE: the Korea Association Resource project.
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that reached nominal significance (P < 0.05). Conse-
quently, we identified six OA genomic regions that confer
susceptibility and/or protection. These regions included
TNKS, CA10, POSTN, MAMDC2, KCND3, and ME3
which encompassed or were near CNV regions.
The canonical Wnt/β-catenin signaling pathway has
been implicated in the pathogenesis of osteoarthritis
[19]. Increased β-catenin accumulations have been ob-
served in degenerative cartilage, suggesting that activated
Wnt signaling might contribute to progression of osteo-
arthritis by downstream target genes such as matrix me-
talloproteinases (MMPs) [20]. For instance, the secreted
Wnt antagonist Dickkopf-1 is related with slowed pro-
gression of hip OA in elderly women [21] and the small
molecule XAV939, which selectively inhibits β-catenin-
mediated transcription, is associated with protecting car-
tilage degradation in a rat osteoarthritis model [22]. Tan-
kyrase, which is encoded by TNKS, bind directly to axin,
a negative regulator of the canonical Wnt/β-catenin sig-
naling pathway, forming a destruction complex with
glycogen synthase kinase 3β (GSK-3β) and adenomatous
polyposis coli (APC) to degrade β-catenin [23]. Inhib-
ition of TNKS by treating the compound XAV939 or
small interfering mediated silencing of TNKS can cause
an increase in levels of axin, leading to phosphorylation
and degradation of β-catenin, and inhibition of target
gene transcription by Wnt signaling. Thus, although fur-
ther studies are needed to establish the role of TNKS in
osteoarthritis through axin-mediated inhibition of Wnt
signaling, it is quite possible that TNKS could be risk
factor for osteoarthritis.
Figure 1 shows the chromosomal position of the copy
number deletion of third intron of TNKS. Interestingly,
several transcription factor binding sites as determinedTable 3 Summary of association result
Chr Start End Length (bp) Gene OA t
1 112490851 112509390 18539 Upstream of KCND3 Hand
8 9535412 9536779 1367 Intron of TNKS Hand
9 71952096 71953157 1061 Intron of MAMDC2 Knee
11 85981796 85983048 1252 Intron of ME3 Hand
13 36971042 36976531 5489 Downstream of POSTN Hand
17 47477132 47478158 1026 Intron of CA10 Hand
aDesignations for the CNV genotype are as indicated in the Methods. A dash indica
gender, age, and body mass index; OR: odds ratio, CI: Confidence interval.by ENCODE of UCSC genome browser (http://genome.
ucsc.edu/ENCODE) overlapped with this CNV region
(Figure 1B). We speculated that copy number deletion of
this region may directly or indirectly influence the binding
of transcription factors, possibly including JunD, which be-
longs to the Jun family of activator protein 1 transcriptional
regulators. A recent study reported that JunD-deficient
immortalized fibroblast exhibit increased proliferation
[24]. JunD also regulates interleukin-6 and matrix
metalloproteinase-9 transcription in hepatic stellate cells,
indicating that JunD may be a key profibrogenic regulator
[25]. Copy number deletion of TNKS was associated with
a 1.37-fold decreased risk for OA (Table 2).
CA10 gene encodes a protein that belongs to the car-
bonic anhydrase family of zinc metalloenzymes, which
catalyze the reversible hydration of carbon dioxide [26].
The protein encoded by CA10 is an acatalytic member of
the alpha-carbonic anhydrase subgroup, which includes
major players in many physiological processes including
renal and male reproductive tract acidification and bone
resorption. Carbonic anhydrases are thought to be in-
volved in bone mineral solubilization and digestion of or-
ganic bone matrix by acid proteases. The rapid conversion
of carbon dioxide to bicarbonate and protons occurs while
maintaining a normal intracellular pH in osteoclasts [27].
The use of an inhibitor of carbonic anhydrase is associated
with a bone-sparing effect, as shown by measurement of
spinal bone mineral density [28]. Moreover, the intronic
variants, rs2106329 in CA10 shows strong association with
osteoporosis in Japanese women [29]. A homozygous A al-
lele at rs2106329 is a protective factor for osteoporosis. In
our study, copy number deletion on CA10 was associated
with a 1.69-fold decrease risk for hand OA as compared
with a normal copy number (Table 3). Copy number dele-
tion can also be a protective factor for OA.ype CNV genotype frequency (%)a OR (95% CI)b Adjusted
P-valuecCases (0/1/2) Controls (0/1/2)
23.0/52.9/24.0 13.1/52.5/34.5 0.41 (0.25 - 0.68) 5.8 × 10-4
, Knee 2.4/28.8/68.7 4.3/34.5/61.2 1.37 (1.02 - 1.85) 3.5 × 10-2
-/7.2/92.8 -/3.0/97.0 0.36 (0.16 - 0.86) 1.9 × 10-2
6.9/33.3/59.8 11.1/40.5/48.4 1.70 (1.21 - 2.40) 2.4 × 10-3
, Knee 2.4/31.3/66.3 1.5/22.5/76.0 0.64 (0.47- 0.87) 4.9 × 10-3
1.5/19.1/79.4 2.8/26.6/70.7 1.69 (1.14 - 2.55) 1.02 × 10-2
tes a zero-copy CNV region. ORb and Adjusted P-valuec were adjusted by
Table 4 Result of TaqMan copy number assays
Chr Start End Probe ID CNV genotypea TP FP PPVb
Chr1 112490851 112509390 Hs_03201731_cn 0, 1, 2 179 9 0.95
Chr8 9535412 9536779 Hs_04345744_cn 0, 1, 2 73 1 0.99
Chr9 71952096 71953157 Hs_06899364_cn 1, 2 58 1 0.98
Chr11 85981796 85983048 Hs_03777027_cn 0, 1, 2 70 4 0.95
Chr13 36971042 36976531 CCT956B 0, 1, 2 85 3 0.97
Chr17 47477132 47478158 CCD1TXG 0, 1, 2 86 0 1.00
aDesignations for the CNV genotype are as indicated in the Methods. bPPV: positive predictive value, PPV is defined as number of TPs/(number of TPs + number of FPs).
Figure 1 A copy-number deletion at chromosomal position 8p23.1. The detected CNV region in this study is marked by green filled square.
The coordinate of the CNV region were recalculated based on hg19 by liftOver of UCSC genome browser. (A) CNV region overlapped with
previously reported CNV regions from Database of Genomic Variants. (B) Several transcription factor binding sites as determined by ENCODE
were found within this CNV region, indicating that copy-number deletion of this region may influence genetic regulation.
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that functions as a ligand for αV/β3 and αV/β5 integrins
to support adhesion and migration of epithelial cells [30].
Periostin is a matricellular glutamate-containing protein
that is expressed in connective tissues including bone,
periosteum, and ligament [31]. Periostin is believed to
function in the regulation of bone formation and, with its
preferential localization in the periosteum, may play a role
in fracture repair during the early process of bone regener-
ation [31]. In response to mechanical stress, periostin ex-
pression is up-regulated and collagen fibrillogenesis and
matrix organization occur to preserve tissue integrity and
function [32]. Periostin knock-out mice show altered cor-
tical bone microarchitecture and lower bone mineral
density [33]. Periostin appears to influence the properties
of bone materials and damage accumulation and repair,
including local modeling/remodeling processes in re-
sponse to fatigue [34]. Periostin deficiency may influence
the propensity for fatigue fractures [34], and may acceler-
ate the pathogenesis of OA in cooperation with an imbal-
ance in bone repair mechanisms. Similar to previously
reported study, in our study, copy number deletion down-
stream of POSTN was associated with an increase in the
risk for hand and/or knee OA compared with the normal
copy number. However, we did not find a relationship be-
tween this CNV region and POSTN.
Also, we could not find a biological role of MAMDC2,
KCND3, and ME3 in the pathogenesis of OA.
The present study has some limitations. First, diagnosis
of OA was radiologically based (i.e., using X-ray) without
assessment of symptoms. Different methods of assessment
such as self-reported and symptomatic OA could not be
available in population-based study samples. This limita-
tion has resulted in small sample size of discovery stage
and a difficulty of collecting samples for replication ana-
lysis. Second, because of first limitation which was men-
tioned above, we did not success to find radiographic case
samples in independent general population samples. Even-
tually, we did not conduct a replication study, which is
highly desirable with association studies. This limitation
can be solved through a meta-analysis with other data in
the future. To reduce heterogeneity of meta-analysis, we
provide our cohort information such as exact phenotype
definition, cut-off, and number of cases of each OA type.
Third, knee and hand OA were analyzed together. OA of
the knee can be a component of a generalized diathesis,
including OA of the hand, which may be inherited. The
OA phenotype is heterogeneous and occurs at specific
joint locations, in a more generalized form, or with and
without clinical presentation. Each phenotype has its own
heritability estimate [35]. Fourth, the sample size was rela-
tively small, and this reduced the power of the analysis.
Fifth, six novel CNVs were located not in exons but in in-
trons or were intergenic. Despite these limitations, ourstudy has the following strengths. First, the present study
describes the first CNVs to be reported regarding OA
using high-resolution chip. Second, we were able to define
precise disease phenotype using X-rays of all the
participants.
Conclusions
We identified several previously unreported CNV loci
that predisposed to or provided protection from OA.
Identification of the associated variants at these genomic
loci and their potential functional consequences will lead
to better understanding of the pathogenesis of OA. Al-
though this study has some limitations, further func-
tional investigations of these genes are warranted to fully
characterize the association.
Additional files
Additional file 1: Overall scheme of this study. A genome-wide
association study of CNVs was conducted using 371 of OA cases and 467
controls. Consequently, six candidate CNV regions were selected.
Additional file 2: Result of CNVtools with estimated genotypes and
Log2 ratio information. We used LDF value among three different
genotype information such as raw, PCA, and LDF. PCA: Principal
components analysis, LDF: linear discrimination function.
Additional file 3: CNV classes. For the CNV genotyping stage, we
assigned individuals to each CNV cluster according to the log2 ratio
between test sample and reference sample. (A) Single-class CNVs, in
which all individuals of the CNV region belonged to one cluster, were
excluded from further study. (B, C) Only multi-class CNVs that consisted
of two (B) or three (C) clusters were used for the association analysis.
Additional file 4: Genotypes and validation results of the CNV
region on TNKS. (A) The Histogram represents the signal intensity of
log2 ratio for OA cases (left) and controls (right). CNV genotypes of this
region were clearly separated into three groups (homozygous deletion,
heterozygous deletion and normal). The colored lines (black, green and
cyan) show the posterior probability for each of the three copy number
classes (homozygous deletion, heterozygous deletion and normal copy).
(B) Quantitative PCR results showed that the validated genotype was highly
concordant with estimated CNV genotype. The copy number state of cases
(left) and control samples (right). Higher bar, lower bar and no bar in each
figure represent a normal number of copies, heterozygous deletion, and
homozygous deletion, respectively. The Blue bar means copy number state
of the NA10851 sample, which was used as the reference sample.
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